Evaluation of a Program to Improve the Life Quality of Elderly (VR_LIFE)
November 28, 2024 updated by: Dèlia Borda Fortuny, Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
The Influence of Using Virtual Reality Glasses on the Quality of Life of the Elderly
Older people belong to an age group that has been increasing in recent decades, leading to a progressive ageing of the population.
With the aim of reducing the generational digital divide, the use of technology in retirement homes was proposed.
To this end, virtual reality glasses were used to allow the visualization of an external virtual world and, subsequently, it was evaluated whether their application improved the quality of life of the elderly by reducing the difficulties they have in participating in recreational activities outside these centers.
A prospective quasi-experimental longitudinal study was carried out in the centers belonging to the basic health area of Valls, with a study period from May 2023 to March 2024.
Quality of life was measured using the ad hoc "Escala de Calidad de Vida Rivas-Bordas".
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Lleida
-
Bellcaire d'Urgell, Lleida, Spain, 25337
- Delia Borda Fortuny
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age 65 or older.
- Resident of a geriatric home in the Valls area.
- Individuals with slight, moderate, fair, or total impairment of social resources, as assessed by the Duke University Center (1978) Social Resources Scale (OARS).
Exclusion Criteria:
- Individuals with a history of frequent migraines or motion sickness.
- Individuals with moderate or severe cognitive impairment (≥ 5 errors on the Abbreviated Pfeiffer test).
- Inability to communicate in Spanish and/or Catalan.
- Individuals with advanced visual and/or hearing impairments.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Intervention
A pretest was conducted with a group of elderly residents from three different nursing homes.
Following this, participants watched 360-degree VR videos featuring nature walks, trips, and similar experiences for 10 minutes, once a week, over a period of four weeks.
After completing the VR sessions, a posttest was administered.
The results will be used to assess the participants' Quality of Life and their Satisfaction with the intervention.
|
The group first completed a pretest, after which they watched 360-degree VR videos, such as nature walks and trips, for 10 minutes once a week over four weeks.
Following this, a posttest was conducted.
The outcomes will be used to measure changes in Quality of Life.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of Quality of Life
Time Frame: pre-intervention and immediately after post-intervention
|
The Quality of Life was evaluated using the ad hoc "Rivas-Borda Quality of Life Scale." Developed by the principal investigators, it consists of 26 items. The scale measures participants' Quality of Life across four areas (emotional, cognitive, socio-economic, and physical) using a 4-point Likert scale (1 = Never or almost never, 4 = Always or almost always). The lowest possible score on the scale is 23, and the highest is 104. A score between 104 and 81 indicates an adequate Quality of Life, between 80 and 54 points suggests a risk of Quality of Life deterioration, and between 53 and 23 indicates an altered Quality of Life. At the end of the scale, there are 3 additional questions assessing satisfaction with the activity, also rated on a 4-point Likert scale (1 = Not at all, 4 = Very much). |
pre-intervention and immediately after post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gender
Time Frame: pre-intervention
|
Female, Male or Non-binary
|
pre-intervention
|
|
Marital Statuts
Time Frame: pre-intervention
|
Single, widowed, married or in a partner living in the residence or married or in a partner who does not live in the residence.
|
pre-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 2, 2022
Primary Completion (Actual)
September 2, 2022
Study Completion (Actual)
April 15, 2024
Study Registration Dates
First Submitted
September 18, 2024
First Submitted That Met QC Criteria
October 30, 2024
First Posted (Actual)
October 31, 2024
Study Record Updates
Last Update Posted (Actual)
December 3, 2024
Last Update Submitted That Met QC Criteria
November 28, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 23/155-P
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.